Unveiling Proteins: The Future Of Single-Cell Proteomics With Professor Nikolai Slavov

Oct 10, 2024

In this insightful chat, Professor Nikolai Slavov, an expert in bioengineering at Northeastern University, delves into the groundbreaking world of single-cell proteomics. He discusses the central dogma of biology, emphasizing the importance of proteins in drug development. Professor Slavov shares the challenges of measuring complex protein interactions and the underfunding issues plaguing proteomics research. The conversation highlights advanced technologies like mass spectrometry, revealing their potential to transform diagnostics and biopharma R&D.

Ask episode

Chapters

Transcript

Episode notes

Intro

00:00 • 2min

Unraveling Multiomics

01:57 • 4min

Innovations and Challenges in the Proteomics Landscape

06:26 • 2min

Advancements in Protein Analysis and Drug Development

08:08 • 29min

Contrasting Approaches in Protein Study: Challenges and Future Directions

37:28 • 6min

Advancements in Single-Cell Proteomics

43:22 • 20min

Exploring the Future of Protein Research and Accessibility

01:03:25 • 5min

Challenges and Opportunities in Proteomics Research

01:08:03 • 3min

In this episode of FYI, Brett Winton, ARK's Chief Futurist, and Nemo Marjanovic, ARK's Multiomics Analyst, have an in-depth discussion with Professor Nikolai Slavov from Northeastern University. Professor Slalov is the Director of Parallel Squared Technology Institute (PTI). Together they explore the fascinating and complex world of multiomics, focusing on the importance of proteomics in understanding biological processes. Professor Slavov shares his insights on the technological advancements in single-cell proteomics, the challenges in measuring protein interactions, and the critical role of proteomics in drug development. The conversation also delves into the underfunded nature of proteomics research and its potential to revolutionize biopharma R&D and diagnostics.

Key Points From This Episode:

Introduction to multi-omics and its relevance in modern biology.
Explanation of the central dogma of molecular biology: DNA, RNA, and proteins.
Overview of Professor Slavov's research on single-cell proteomics and its implications.
Challenges in measuring the dynamic and complex nature of the proteome.
The role of advanced technologies like mass spectrometry in proteomic analysis.
Importance of protein interactions and modifications in cellular functions.
Discussion on the underfunding of proteomics research and its impact on scientific progress.
The potential of proteomics to improve drug development and diagnostic precision.
Advances in AI and data analysis techniques for better understanding protein structures and functions.
Future frontiers in proteomics, including improved technology access and dynamic protein measurements.

References:

MacCoss, M.J., Alfaro, J.A., Faivre, D.A. et al. Sampling the proteome by emerging single-molecule and mass spectrometry methods. Nat Methods 20, 339–346 (2023). https://doi.org/10.1038/s41592-023-01802-5

Derks J, Jonson T, Leduc A, Khan S, Khoury L, Rafiee M, Slavov N Single-nucleus proteomics identifies regulators of protein transport

bioRxiv doi: 10.1101/2024.06.17.599449 (2024)